Verily & Nikon to Collaborate on Machine Learning in Diabetes

While many were enjoying their end of year holidays, Google’s life sciences company Verily was busy completing one final business deal of 2016. Verily’s alliance is with Nikon’s retinal imaging subsidiary Optos, which aims to leverage machine learning in the development of improved care solutions for diabetic retinopathy (DR) and diabetic macular oedema (DME). The collaboration will look to create better screening methods for both conditions as well as assisted reading programmes to help specialists diagnose either disease. Verily brings machine learning prowess to the deal whilst Optos will apply its core imaging technologies, including its retina imaging platform Optomap which can capture around 82% and 200o of the retina in one image. According to the World Health Organisation, the number of people with diabetes is rapidly increasing worldwide, particularly in low and middle income…


Link to Full Article: Verily & Nikon to Collaborate on Machine Learning in Diabetes